SEARCH

SEARCH BY CITATION

References

  • Aguilar-Bryan L & Bryan J (1999). Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20, 101135.
  • Aguilar-Bryan L, Clement JP, Gonzalez G, Kunjilwar K, Babenko A & Bryan J (1998). Toward understanding the assembly and structure of K-ATP channels. Physiol Rev 78, 227245.
  • Anderson RGW (1998). The caveolae membrane system. Annu Rev Biochem 67, 199225.
  • Barrett-Jolley R, Dart C & Standen NB (1999). Direct block of native and cloned (Kir2.1) inward rectifier K+ channels by chloroethylclonidine. Brit J Pharmacol 128, 760766.
  • Beech DJ, Zhang H, Nakao K & Bolton TB (1993a). K channel activation by nucleotide diphosphates and its inhibition by glibenclamide in vascular smooth muscle cells. Br J Pharmacol 110, 573582.
  • Beech DJ, Zhang H, Nakao K & Bolton TB (1993b). Single channel and whole-cell K currents evoked by levcromakalim in smooth muscle cells from the rabbit portal vein. Br J Pharmacol 110, 583590.
  • Chutkow WA, Pu JL, Wheeler MT, Wada T, Makielski JC, Burant CF & McNally EM (2002). Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K-ATP channels. J Clin Invest 110, 203208.
  • Clapp LH & Tinker A (1998). Potassium channels in the vasculature. Curr Opin Nephrol Hypertens 7, 9198.
  • Clark JF, Kemp GJ & Radda GK (1995). The creatine-kinase equilibrium, free [ADP] and myosin ATPase in vascular smooth muscle cross bridges. J Theor Biol 173, 207211.
  • Cole WC & Clement-Chomienne O (2003). ATP-sensitive K+ channels of vascular smooth muscle cells. J Cardiovasc Electrophysiol 14, 94103.
  • Couet J, Li SW, Okamoto T, Ikezu T & Lisanti MP (1997). Identification of peptide and protein ligands for the caveolin-scaffolding domain: Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272, 65256533.
  • Farouque HMO, Worthley SG, Meredith IT, Skyrme-Jones PAP & Zhang MJ (2000). Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans. In 73rd Scientific Sessions of the American Heart Association, pp. 231236.
  • Fielding CJ, Bist A & Fielding PE (1997). Caveolin mRNA levels are up-regulated by free cholesterol and down-regulated by oxysterols in fibroblast monolayers. Proc Natl Acad Sci U S A 94, 37533758.
  • Galbiati F, Razani B & Lisanti MP (2001). Emerging themes in lipid rafts and caveolae. Cell 106, 403411.
  • Garg V, Jiao JD & Hu KL (2009a). Regulation of ATP-sensitive K+ channels by caveolin-enriched microdomains in cardiac myocytes. Cardiovasc Res 82, 5158.
  • Garg V, Sun W & Hu KL (2009b). Caveolin-3 negatively regulates recombinant cardiac K-ATP channels. Biochem Biophys Res Commun 385, 472477.
  • Hailstones D, Sleer LS, Parton RG & Stanley KK (1998). Regulation of caveolin and caveolae by cholesterol in MDCK cells. J Lipid Res 39, 369379.
  • Innocenti B, Pozzan T & Fasolato C (1996). Intracellular ADP modulates the Ca2+ release-activated Ca2+ current in a temperature- and Ca2+-dependent way. J Biol Chem 271, 85828587.
  • Jiao JD, Garg V, Yang BF, Elton TS & Hu KL (2008). Protein kinase C-ɛ induces caveolin-dependent internalization of vascular adenosine 5′-triphosphate sensitive K+ channels. Hypertension 52, 499506.
  • Leyland ML & Dart C (2004). An alternatively spliced isoform of PSD93/Chapsyn 110 binds to the inwardly rectifying potassium channel, Kir2.1. J Biol Chem 279, 4342743436.
  • Mathew V, Cannan CR, Miller VM, Barber DA, Hasdai D, Schwartz RS, Holmes DR & Lerman A (1997). Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia. Circulation 96, 19301936.
  • Merkel LA & Bilder GE (1992). Modulation of vascular reactivity by vasoactive peptides in aortic rings from hypercholesterolemic rabbits. Eur J Pharmacol 222, 175179.
  • Miki T, Suzuki M, Shibasaki T, Uemura H, Sato T, Yamaguchi K, Koseki H, Iwanaga T, Nakaya H & Seino S (2002). Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med 8, 466472.
  • Moreau R, Komeichi H, Kirstetter P, Yang S, Aupetitfaisant B, Cailmail S & Lebrec D (1994). Effects of glibenclamide on systemic and splanchnic hemodynamics in conscious rats. Br J Pharmacol 112, 649653.
  • Okamoto T, Schlegel A, Scherer PE & Lisanti MP (1998). Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane. J Biol Chem 273, 54195422.
  • Parton RG & Simons K (2007). The multiple faces of caveolae. Nat Rev Mol Cell Biol 8, 185194.
  • Patel HH, Murray F & Insel PA (2008). Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu Rev Pharmacol Toxicol 48, 359391.
  • Qin F (2004). Restoration of single-channel currents using the segmental k-means method based on hidden Markov modeling. Biophys J 86, 14881501.
  • Qin F, Auerbach A & Sachs F (1996). Estimating single-channel kinetic parameters from idealized patch-clamp data containing missed events. Biophys J 70, 264280.
  • Qin F, Auerbach A & Sachs F (1997). Maximum likelihood estimation of aggregated Markov processes. Proc R Soc Lond B Biol Sci 264, 375383.
  • Quayle JM, Nelson MT & Standen NB (1997). ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev 77, 11651232.
  • Razani B, Woodman SE & Lisanti MP (2002). Caveolae: From cell biology to animal physiology. Pharmacol Rev 54, 431467.
  • Romerio SC, Linder L, Flammer J & Haefeli WE (2000). Correlation between apolipoprotein B and endothelin-1-induced vasoconstriction in humans. Peptides 21, 871874.
  • Samaha FF, Heineman FW, Ince C, Fleming J & Balaban RS (1992). ATP-sensitive potassium channel is essential to maintain basal coronary vascular tone in vivo. Am J Physiol Cell Physiol 262, C1220C1227.
  • Sampson LJ, Davies LM, Barrett-Jolley R, Standen NB & Dart C (2007). Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATP-sensitive potassium channels. Cardiovasc Res 76, 6170.
  • Sampson LJ, Hayabuchi Y, Standen NB & Dart C (2004). Caveolae localize protein kinase A signaling to arterial ATP-sensitive potassium channels. Circ Res 95, 10121018.
  • Satoh E, Yamada M, Kondo C, Repunte VP, Horio Y, Iijima T & Kurachi Y (1998). Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modification by pinacidil. J Physiol 511, 663674.
  • Seino S (1999). ATP-sensitive potassium channels: A model of heteromultimeric potassium channel/receptor assemblies. Annu Rev Physiol 61, 337362.
  • Yokoshiki H, Sunagawa M, Seki T & Sperelakis N (1998). ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol Cell Physiol 43, C25C37.
  • Yoon HY, Hwang SH, Lee EY, Kim TU, Cho EH & Cho SW (2001). Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine. Biochimie 83, 907913.
  • Zhang HL & Bolton TB (1996). Two types of ATP-sensitive potassium channels in rat portal vein smooth muscle cells. Br J Pharmacol 118, 105114.